Abstract: A pharmaceutical composition for treating lifestyle-related diseases including type 2 diabetes and obesity-related disease. The pharmaceutical composition includes a compound represented by the following formula (1) or a salt thereof as an active ingredient.
Type:
Application
Filed:
March 15, 2023
Publication date:
January 1, 2026
Applicants:
NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY, SCIENCE FARM LTD.
Abstract: The present invention provides a pharmaceutical composition for preventing and/or treating a disease characterized by fibrosis of a cell or a tissue, the pharmaceutical composition comprising a compound represented by formula 1 or a salt thereof, and a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
January 30, 2020
Date of Patent:
November 12, 2024
Assignees:
SCIENCE FARM LTD., LINK GENOMICS, INC.
Inventors:
Lin Kurahara, Hironobu Ihn, Masami Otsuka
Abstract: The present invention provides a pharmaceutical composition for preventing and/or treating a disease characterized by fibrosis of a cell or a tissue, the pharmaceutical composition comprising a compound represented by formula 1 or a salt thereof, and a pharmaceutically acceptable carrier.
Type:
Application
Filed:
January 30, 2020
Publication date:
March 31, 2022
Applicants:
SCIENCE FARM LTD., LINK GENOMICS, INC.
Inventors:
Lin KURAHARA, Hironobu IHN, Masami OTSUKA